The Commercial Power Division of EaglePicher Technologies LLC (Joplin, MO) has signed a long-term agreement with NanoGram Devices Corp. to develop and manufacture batteries based on NanoGram’s patented nanomaterial technology. The initial application of the technology will be for batteries in implantable medical devices. The agreement also outlines plans for further collaboration and provides EaglePicher with the potential to license the technology in other markets, including aerospace and defense.
The strategic alliance combines the development and manufacturing capabilities of EaglePicher's Commercial Power business with the proven nanotechnology of NanoGram Devices. As part of the new venture, EaglePicher is establishing a dedicated manufacturing operation for medical batteries. The first products produced under the agreement will be NanoGram Devices’ NanoCardia™ line of high-performance, medical power sources used to power implantable cardioverter defibrillators.
"EaglePicher is excited to help NanoGram Devices bring this breakthrough technology to market," said Kevin Quinn, vice president and general manager of EaglePicher Technology’s Commercial Power division. "We believe that nanomaterial technology offers significant improvements in battery performance, reliability and miniaturization. NanoGram is the clear leader in the application of this technology to batteries. This new venture furthers our commitment to the medical market and provides us with a terrific platform for additional developments in high-performance battery technology."
